clinical research platform

By Dave Muoio March 14, 2019
Clinical trial data analysis company TriNetX has raised $40 million in a Series D funding round led by Merck Global Health Innovation Fund. Also participating in the round were new investors Mitsui & Co. and Itochu Technology Ventures, and returning backers MPM Capital, F2 Ventures and Deerfield Management. Announced yesterday, the new investments bring TriNetX’s total funding to $102 million...